StatsCure Network (@statscure) header
StatsCure Network (@statscure) profile picture

StatsCure Network

@statscure

Revolutionizing Patient Care with Advanced Data Analytics Solutions.

 Mumbai
statscure.co.in
Joined November 2024
  • Tweets98
  • Following112
  • Followers13
75Media
Photo by StatsCure Network (@statscure)Photo by StatsCure Network (@statscure)Photo by StatsCure Network (@statscure)Photo by StatsCure Network (@statscure)Photo by StatsCure Network (@statscure)Photo by StatsCure Network (@statscure)Photo by StatsCure Network (@statscure)Photo by StatsCure Network (@statscure)Photo by StatsCure Network (@statscure)Photo by StatsCure Network (@statscure)
Applications open! Join the 6-month GSP Programme for Oncology Researchers by StatsCure Network & CRSF. Live online | Starts 21 Nov 2026 25 seats | Deadline: 31 Oct Scan the flyer to register. #Biostatistics #ClinicalResearch #clinicians
Join the 6-month Good Statistical Practice (GSP) Programme for Oncology Researchers by StatsCure Network and CRSF. 📚 3 months of live training + 3 months of research mentorship 🔬 Research methodology, biostatistics, study design, survival analysis and hands-on practice 🌍 Live online, open to global participants 📅 Starts: 21 November 2026 💰 Fee: ₹20,000 / US$350 🎯 Only 25 seats available ⏳ Registration deadline: 31 October 2026 Scan the QR code on the flyer to register. For enquiries: admin@statscure.co.in #Biostatistics #OncologyResearch #ClinicalResearch

ALT Join the 6-month Good Statistical Practice (GSP) Programme for Oncology Researchers by StatsCure Network and CRSF. 📚 3 months of live training + 3 months of research mentorship 🔬 Research methodology, biostatistics, study design, survival analysis and hands-on practice 🌍 Live online, open to global participants 📅 Starts: 21 November 2026 💰 Fee: ₹20,000 / US$350 🎯 Only 25 seats available ⏳ Registration deadline: 31 October 2026 Scan the QR code on the flyer to register. For enquiries: [email protected] #Biostatistics #OncologyResearch #ClinicalResearch

11
Can specialist referral improve cardiovascular risk management in prostate cancer patients? A randomized trial of 2,487 patients found better cholesterol control and greater statin use, but no significant difference in major cardiovascular events. #ClinicalResearch #Biostatistics
Image from StatsCure Network (@statscure)
4
Turning clinical data into reliable research insights starts with the right statistical approach. StatsCure supports researchers with study design, sample size estimation, statistical analysis & data visualization. 📩 [email protected] #Biostatistics #ClinicalResearch
8
A randomized clinical trial found that specialist referral improved cholesterol control in patients with prostate cancer, but did not significantly reduce major cardiovascular events. A key insight for clinical research and biostatistics. #ClinicalResearch #ClinicalTrials
Clinical trial infographic highlighting cardiovascular risk management in prostate cancer patients, improved cholesterol control, increased statin use, and no significant difference in major cardiovascular events.

ALT Clinical trial infographic highlighting cardiovascular risk management in prostate cancer patients, improved cholesterol control, increased statin use, and no significant difference in major cardiovascular events.

12
Strengthen your clinical research skills with the Good Statistical Practice (GSP) Program by StatsCure in collaboration with CRSF. 3 months of live training + 3 months of mentorship Online | 2 hours every Saturday For clinicians worldwide #ClinicalResearch #Biostatistics
Image from StatsCure Network (@statscure)
2
39
Can exosomes predict hidden liver metastasis in pancreatic cancer? A miRNA signature shows promising potential for early risk prediction. #ClinicalResearch #Biostatistics #PancreaticCancer
Image from StatsCure Network (@statscure)
14
Higher saturated-fat intake after prostate cancer diagnosis was linked to higher mortality, while replacing saturated fat with monounsaturated fat was associated with lower mortality. #ProstateCancer #Oncology #ClinicalResearch
Image from StatsCure Network (@statscure)
1
1
26
Is Pleomorphic Dermal Sarcoma (PDS) genetically closer to metastatic cSCC? A recent study found similar molecular profiles between PDS and metastatic cSCC, including 100% UV-signature mutations in PDS. These findings may inform future treatment strategies. #Oncology
Image from StatsCure Network (@statscure)
9
ERBB2+ Breast Cancer: 5-Year Outcomes Clinical research reports encouraging long-term outcomes, including 99% 5-year event-free survival and 96.1% ctDNA clearance after neoadjuvant THP—supporting further research into ctDNA-guided treatment de-escalation. #BreastCancer #ctDNA
Image from StatsCure Network (@statscure)
14
CD19/CD22 CAR-T therapy shows promising outcomes in pediatric B-ALL 99.2% MRD-negative remission 85.7% vs 57.9% 24-month EFS 261 patients A promising approach for deep and durable disease control, with further research needed on long-term outcomes. #CARTCellTherapy #Oncology
Image from StatsCure Network (@statscure)
19
Clinical Research Insights | Oncology A Phase 3 trial in ERBB2-positive breast cancer (521 patients) reported: 📊 tpCR: 62.4% vs 51.2% 📈 Difference: 11.4% | P=.004 🛡️ Grade 3–4 AEs: 29.3% vs 28.3% #ClinicalResearch #Oncology #Biostatistics #ClinicalTrials
StatsCure clinical research infographic on a Phase 3 trial in ERBB2-positive breast cancer. The study included 521 patients and reported a 62.4% vs 51.2% pathological complete response rate, with an 11.4 percentage-point difference and P=.004. Grade 3–4 adverse events were 29.3% vs 28.3%.

ALT StatsCure clinical research infographic on a Phase 3 trial in ERBB2-positive breast cancer. The study included 521 patients and reported a 62.4% vs 51.2% pathological complete response rate, with an 11.4 percentage-point difference and P=.004. Grade 3–4 adverse events were 29.3% vs 28.3%.

14
Clinicians involved in clinical research your input matters! We’re conducting a 2–3 min survey on real-world challenges in clinical research, study design & biostatistics. forms.gle/unJ7VvWS1sAhsjYN8 Please participate and share with fellow clinicians involved in research.
Clinical Research & Biostatistics Needs Assessment 2026

Clinical Research & Biostatistics Needs Assessment 2026

By StatsCure Network We are conducting a short survey to understand the real-world challenges clinicians face in clinical research, study design, and biostatistics. Your responses will help StatsCure...

docs.google.com
18
This Week in Clinical Research 🧬📊 Key updates across clinical trials, regulatory science, real-world evidence, AI in research, and pharma developments. Stay updated. Stay evidence-driven. #ClinicalResearch #ClinicalTrials #Biostatistics #Pharma #CRO #DrugDevelopment
Infographic titled “This Week in Clinical Research” highlighting five areas of clinical research: Phase 3 trial results, regulatory developments, new publications, AI-powered clinical research technology, and pharma industry announcements. The graphic features a clinical researcher using a microscope in a laboratory setting, with scientific and healthcare icons. Target Keywords Clinical Research, Clinical Trials, Biostatistics, Pharmaceutical Research, CRO, Drug Development, Real-World Evidence, Clinical Data, Medical Research, Statistical Analysis, Study Design, Clinical Research Support More Targeted Hashtags for Reach Primary: #ClinicalResearch #ClinicalTrials #Biostatistics #DrugDevelopment #PharmaceuticalResearch Target audience: #CRO #ClinicalResearchProfessionals #ClinicalOperations #MedicalResearchers #HealthcareProfessionals #PharmaProfessionals #ClinicalData #ResearchScientists Service-related: #StatisticalAnalysis #StudyDesign #RealWorldEvidence #DataVisualization

ALT Infographic titled “This Week in Clinical Research” highlighting five areas of clinical research: Phase 3 trial results, regulatory developments, new publications, AI-powered clinical research technology, and pharma industry announcements. The graphic features a clinical researcher using a microscope in a laboratory setting, with scientific and healthcare icons. Target Keywords Clinical Research, Clinical Trials, Biostatistics, Pharmaceutical Research, CRO, Drug Development, Real-World Evidence, Clinical Data, Medical Research, Statistical Analysis, Study Design, Clinical Research Support More Targeted Hashtags for Reach Primary: #ClinicalResearch #ClinicalTrials #Biostatistics #DrugDevelopment #PharmaceuticalResearch Target audience: #CRO #ClinicalResearchProfessionals #ClinicalOperations #MedicalResearchers #HealthcareProfessionals #PharmaProfessionals #ClinicalData #ResearchScientists Service-related: #StatisticalAnalysis #StudyDesign #RealWorldEvidence #DataVisualization

12
Research Article Insight | RATIONALE-306 36-month follow-up of the Phase 3 trial of tislelizumab + chemotherapy in advanced ESCC: 📊 OS: 17.2 vs 10.6 months HR 0.70 | 3-year PFS: 15.0% vs 2.9% Long-term follow-up helps assess the durability of treatment benefit. #Oncology #ESCC
Image from StatsCure Network (@statscure)
44
Publication of the Week | TNBC Phase 3 NSABP B-59/GeparDouze: atezolizumab + chemotherapy increased pCR in early TNBC (63.3% vs 57.0%), but 4-year EFS was not significantly improved (85.2% vs 81.9%). #TNBC #ClinicalResearch #Biostatistics #Oncology #BreastCancer
Image from StatsCure Network (@statscure)
19
Phase 3 Lung Cancer Update HARMONi trial: Ivonescimab + chemotherapy improved median PFS vs chemotherapy alone in advanced EGFR-mutated NSCLC. 📊 6.8 vs 4.4 months | HR 0.52 #ClinicalResearch #NSCLC #Biostatistics #Oncology
Image from StatsCure Network (@statscure)
62
Register Now: docs.google.com/forms/d/e/1F… 🔬 Diagnostic & Screening Test Evaluation #Biostatistics #ClinicalResearch #OncologyResearch #DiagnosticTesting #MedicalResearch
Image from StatsCure Network (@statscure)
1
1
21
Better treatment doesn’t always mean better outcomes. A Phase 3 trial of adaptive radiotherapy vs standard IMRT in oropharyngeal cancer found improved parotid gland function, but no significant difference in salivary flow,xerostomia,or 2-year survival. #Oncology #ClinicalResearch
Image from StatsCure Network (@statscure)
1
1
23
Turning Clinical Data Into Stronger Evidence From study design to data analysis, RWE and visualization, every step matters in generating meaningful research evidence. #ClinicalResearch #Biostatistics #ClinicalData #RWE #MedicalResearch
StatsCure infographic titled ‘Turning Clinical Data Into Stronger Evidence,’ showing the research journey from study design and sample size estimation to data analysis, real-world evidence and data visualization, with an hourglass containing statistical charts and graphs.

ALT StatsCure infographic titled ‘Turning Clinical Data Into Stronger Evidence,’ showing the research journey from study design and sample size estimation to data analysis, real-world evidence and data visualization, with an hourglass containing statistical charts and graphs.

7
GSP Session 03: Diagnostic & Screening Test Evaluation Registration: gsp-workshops.atanustat.work… #ClinicalResearch #Biostatistics #OncologyResearch #DiagnosticResearch #MedicalResearch
Image from StatsCure Network (@statscure)
8
Load more